Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by Financial Counselors Inc.

Financial Counselors Inc. lowered its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 14.9% during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 32,016 shares of the medical equipment provider’s stock after selling 5,584 shares during the quarter. Financial Counselors Inc.’s holdings in Intuitive Surgical were worth $15,728,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Mirador Capital Partners LP grew its holdings in shares of Intuitive Surgical by 1.4% during the third quarter. Mirador Capital Partners LP now owns 3,526 shares of the medical equipment provider’s stock valued at $1,732,000 after purchasing an additional 50 shares during the last quarter. Consolidated Planning Corp boosted its stake in Intuitive Surgical by 17.4% during the 3rd quarter. Consolidated Planning Corp now owns 8,099 shares of the medical equipment provider’s stock valued at $3,979,000 after purchasing an additional 1,198 shares in the last quarter. Healthcare of Ontario Pension Plan Trust Fund boosted its stake in Intuitive Surgical by 617.1% during the 2nd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 89,069 shares of the medical equipment provider’s stock valued at $39,622,000 after purchasing an additional 76,649 shares in the last quarter. Swiss National Bank boosted its stake in Intuitive Surgical by 0.3% during the 3rd quarter. Swiss National Bank now owns 1,052,800 shares of the medical equipment provider’s stock valued at $517,209,000 after purchasing an additional 3,400 shares in the last quarter. Finally, ABLE Financial Group LLC bought a new position in Intuitive Surgical during the 3rd quarter valued at $604,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Price Performance

Intuitive Surgical stock opened at $538.55 on Thursday. The company has a market capitalization of $191.82 billion, a price-to-earnings ratio of 86.58, a PEG ratio of 5.28 and a beta of 1.39. Intuitive Surgical, Inc. has a one year low of $304.50 and a one year high of $552.00. The company’s fifty day moving average price is $507.94 and its two-hundred day moving average price is $466.79.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, topping the consensus estimate of $1.24 by $0.32. The firm had revenue of $2.04 billion for the quarter, compared to the consensus estimate of $2.01 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. As a group, sell-side analysts anticipate that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current year.

Insiders Place Their Bets

In other news, CFO Jamie Samath sold 108 shares of the firm’s stock in a transaction dated Tuesday, November 26th. The stock was sold at an average price of $542.06, for a total value of $58,542.48. Following the sale, the chief financial officer now directly owns 8,757 shares of the company’s stock, valued at approximately $4,746,819.42. This trade represents a 1.22 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, General Counsel Gary Loeb sold 300 shares of the firm’s stock in a transaction dated Monday, September 9th. The shares were sold at an average price of $475.00, for a total value of $142,500.00. Following the completion of the sale, the general counsel now directly owns 1,595 shares in the company, valued at approximately $757,625. This represents a 15.83 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 50,459 shares of company stock valued at $26,080,251 over the last three months. 0.90% of the stock is currently owned by insiders.

Analysts Set New Price Targets

A number of equities analysts have issued reports on the company. Truist Financial increased their price target on Intuitive Surgical from $520.00 to $570.00 and gave the company a “buy” rating in a research note on Monday, October 14th. The Goldman Sachs Group set a $604.00 price objective on Intuitive Surgical in a research report on Friday, October 18th. BTIG Research increased their price objective on Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a research report on Tuesday. JPMorgan Chase & Co. increased their price objective on Intuitive Surgical from $495.00 to $575.00 and gave the company an “overweight” rating in a research report on Friday, October 11th. Finally, Robert W. Baird increased their price objective on Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a research report on Thursday, October 17th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have issued a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $526.06.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.